RCT2100
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RCT2100, covering 2026-01-16 to 2026-01-16. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2 Study Evaluating Safety and Tolerability of RCT2100 (CFTR mRNA) in Healthy Participants and in Participants With CF [Phase 2]